Spinal fusion implant

Abstract
An implant includes a housing; a blade having a retracted position in the housing and an extended position where the blade extends outwardly from the housing; and a blade actuating component comprising a driven shaft portion and a blade engaging portion. The blade actuating component can move the blade between the retracted position and the extended position. In addition, the blade engaging portion of the blade actuating component has a substantially U-shaped configuration defined at least in part by a superior surface and an inferior surface. Also, when the blade is in the extended position, the superior surface of the blade engaging portion of the blade actuating component is substantially flush with a superior surface of the housing, and the inferior surface of the blade engaging portion of the blade actuating component is substantially flush with an inferior surface of the housing.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. Pat. No. 10,405,992, issued on Sep. 10, 2019 and entitled “Spinal Fusion Implant,” the entire disclosure of which is hereby incorporated by reference.


BACKGROUND

The embodiments are generally directed to implants for supporting bone growth in a patient.


A variety of different implants are used in the body. Implants used in the body to stabilize an area and promote bone ingrowth provide both stability (i.e. minimal deformation under pressure over time) and space for bone ingrowth.


Spinal fusion, also known as spondylodesis or spondylosyndesis, is a surgical treatment method used for the treatment of various morbidities such as degenerative disc disease, spondylolisthesis (slippage of a vertebra), spinal stenosis, scoliosis, fracture, infection or tumor. The aim of the spinal fusion procedure is to reduce instability and thus pain.


In preparation for the spinal fusion, most of the intervertebral disc is removed. An implant, the spinal fusion cage, may be placed between the vertebra to maintain spine alignment and disc height. The fusion (i.e. bone bridge) occurs between the endplates of the vertebrae.


SUMMARY

In one aspect, an implant includes a housing, where the housing has a first axis, a blade, the blade having a retracted position in the housing and an extended position where the blade extends outwardly from the housing, and a blade actuating component, where the blade actuating component includes a driven shaft portion and a blade engaging portion. The blade actuating component can move the blade between the retracted position and the extended position. In addition, the housing includes a first end, where the first end includes a guide opening, and the guide opening has a hollow grooved portion and a chamber portion. The hollow grooved portion is connected to the chamber portion, and the chamber portion receives a portion of the driven shaft portion of the blade actuating component.


In another aspect, an implant includes a body having a first axis, and a blade having a retracted position in the body and an extended position where the blade extends outwardly from the body. The blade has a distal face and a proximal face. In addition, the blade has a bridge portion disposed adjacent to the distal face, where the bridge portion is configured to provide structural reinforcement to the blade. The implant further includes a blade actuating component that can translate through the body in directions parallel to the first axis, and the blade actuating component can move the blade between the retracted position and the extended position.


In another aspect, an implant includes a housing, a first blade, and a blade actuating component. The first blade has a retracted position in the housing and an extended position where the first blade extends outwardly from the housing. In addition, the blade actuating component is configured to translate through the housing in directions parallel to a first axis, where the first axis extends from an anterior side of the implant to a posterior side of the implant. The blade actuating component comprises a driven shaft portion and a blade engaging portion, the driven shaft portion being disposed at least partially outside of the housing when the first blade is the retracted position, and the driven shaft portion being disposed entirely within the housing when the first blade is in the extended position.


Other systems, methods, features and advantages of the embodiments will be, or will become, apparent to one of ordinary skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description and this summary, be within the scope of the embodiments, and be protected by the following claims.





BRIEF DESCRIPTION OF THE DRAWINGS

The embodiments can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, with emphasis instead being placed upon illustrating the principles of the embodiments. Moreover, in the figures, like reference numerals designate corresponding parts throughout the different views.



FIG. 1 is a schematic view of a patient and an implant, according to an embodiment;



FIG. 2 is a schematic view of a patient and an implant with an insertion tool, according to an embodiment;



FIG. 3 is a schematic view of a spine and a deployed implant, according to an embodiment;



FIG. 4 is an isometric view of an embodiment of an implant;



FIG. 5 is an exploded isometric view of the implant of FIG. 4;



FIG. 6 is an isometric superior view of an embodiment of a body of an implant;



FIG. 7 is an isometric inferior view of an embodiment of a body of an implant;



FIG. 8 is a schematic posterior-side view of an embodiment of a body of an implant;



FIG. 9 is a schematic anterior-side view of an embodiment of a body of an implant;



FIG. 10 is a schematic isometric view of an embodiment of a blade actuating component;



FIG. 11 is a schematic anterior-side view of an embodiment of a blade actuating component;



FIG. 12 is a schematic side view of an embodiment of a blade actuating component;



FIG. 13 is a schematic isometric view of an embodiment of a blade;



FIG. 14 is a schematic isometric view of an embodiment of a blade;



FIG. 15 is a schematic view of an embodiment of a blade;



FIG. 16 is a schematic isometric view of an embodiment of a blade actuating component and two corresponding blades;



FIG. 17 is a schematic isometric view of the blade actuating component of FIG. 16 coupled with the two corresponding blades;



FIG. 18 is a schematic isometric view of a superior side of a cover of an implant, according to an embodiment;



FIG. 19 is a schematic isometric view of an inferior side of the cover of FIG. 13;



FIG. 20 is a schematic isometric view of an embodiment of a body and a cover for an implant;



FIG. 21 is a schematic isometric view of an embodiment of a body and a cover for an implant;



FIG. 22 is a schematic isometric view of an implant in a deployed position;



FIG. 23 is a schematic anterior-side view of an implant in a deployed position;



FIG. 24 is a schematic lateral-side view of an implant in a deployed position;



FIG. 25 is a schematic isometric view of an implant in an insertion position, including a cross-sectional view of several components, according to an embodiment;



FIG. 26 is a schematic isometric view of the implant of FIG. 25 in an intermediate position between the insertion position and the deployed position here, including a cross-sectional view of the several components;



FIG. 27 is a schematic isometric view of the implant of FIG. 25 in a deployed position, including a cross-sectional view of the several components;



FIG. 28 is a schematic isometric view of the implant of FIG. 25 in an intermediate position, including a cross-sectional view of the several components;



FIG. 29 is a schematic isometric view of a locking screw according to an embodiment;



FIG. 30 is a schematic side view of the locking screw of FIG. 29;



FIG. 31 is a schematic isometric view of an implant with a locking screw, according to an embodiment;



FIG. 32 is a schematic isometric view of an implant with a locking screw, according to an embodiment;



FIG. 33 is a schematic lateral-side view of a blade actuating component for an implant, according to another embodiment;



FIG. 34 is a cross-sectional view of an a body and a blade actuating component in the insertion position, according to another embodiment;



FIG. 35 is a cross-sectional view of an a body and a blade actuating component in the deployed position, according to another embodiment;



FIG. 36 is a schematic top-down view of an implant and an insertion tool; and



FIG. 37 is a schematic cross-sectional top-down view of the insertion tool with a representation of an implant of FIG. 36.





DETAILED DESCRIPTION

The embodiments described herein are directed to an implant for use in a spine. The embodiments include implants with a body and one or more blades. In addition to the various provisions discussed below, any embodiments may make use of any of the body/support structures, blades, actuating components or other structures disclosed in Duffield et al., U.S. Pat. No. 9,707,100, issued on Jul. 18, 2017 and titled “Interbody Fusion Device and System for Implantation,” Sack, U.S. Pat. No. 10,307,265, issued on Jun. 4, 2019 and titled “Implant With Deployable Blades,” and Duffield et al., U.S. Patent Publication Number 2017/0100260, published on Apr. 13, 2017 and titled “Insertion Tool For Implant And Methods of Use,” each of which are hereby incorporated by reference in their entirety.


Introduction to the Implant



FIG. 1 is a schematic view of an embodiment of an implant 100. For purposes of context, implant 100 is shown adjacent to a depiction of a spinal column 102 in a human body 104. In FIG. 2, an embodiment of implant 100 is shown as it is being inserted into human body 104 with the use of an insertion tool 206. It should be understood that the relative size of implant 100 and insertion tool 206 as depicted with human body 104 have been adjusted for purposes of illustration. For purposes of this disclosure, implant 100 may also be referred to as a cage or fusion device. In some embodiments, implant 100 is configured to be implanted within a portion of the human body. In some embodiments, implant 100 may be configured for implantation into the spine. In some embodiments, implant 100 may be a spinal fusion implant, or spinal fusion device, which is inserted between adjacent vertebrae to provide support and/or facilitate fusion between the vertebrae. For example, referring to FIG. 3, a section of spinal column 102 is illustrated, where implant 100 has been positioned between a first vertebra 192 and a second vertebra 194. Moreover, implant 100 is seen to include two blades (a first blade 241 and a second blade 242), which extend from the superior and inferior surfaces of implant 100. Each of the blades has been driven into an adjacent vertebra (i.e., first vertebra 192 or second vertebra 194) so as to help anchor implant 100.


In some embodiments, implant 100 may be inserted using an anterior lumbar interbody fusion (ALIF) surgical procedure, where the disc space is fused by approaching the spine through the abdomen. In the ALIF approach, a three-inch to five-inch incision is typically made near the abdomen and the abdominal muscles are retracted to the side. In some cases, implant 100 can be inserted through a small incision in the front or anterior side of the body. In some cases, an anterior approach may afford improved exposure to the disc space to a surgeon. The anterior approach can allow a larger device to be used for the fusion, increasing the surface area for a fusion to occur and allowing for more postoperative stability. An anterior approach often makes it possible to reduce some of the deformity caused by various conditions, such as isthmic spondylolisthesis. Insertion and placement of the disc along the front of a human body can also re-establish the patient's normal sagittal alignment in some cases, giving individuals a more normal inward curve to their low back.


For purposes of clarity, reference is made to various directional adjectives throughout the detailed description and in the claims. As used herein, the term “anterior” refers to a side or portion of an implant that is intended to be oriented towards the front of the human body when the implant has been placed in the body. Likewise, the term “posterior” refers to a side or portion of an implant that is intended to be oriented towards the back of the human body following implantation. In addition, the term “superior” refers to a side or portion of an implant that is intended to be oriented towards a top (e.g., the head) of the body while “inferior” refers to a side or portion of an implant that is intended to be oriented towards a bottom of the body. Reference is also made herein to “lateral” sides or portions of an implant, which are sides or portions facing along a lateral direction of the body.



FIG. 4 is a schematic isometric view of an embodiment of implant 100, according to an embodiment. As seen in FIG. 4, implant 100 is understood to be configured with an anterior side 110 and a posterior side 112. Implant 100 may also include a first lateral side 114 and a second lateral side 116. Furthermore, implant 100 may also include a superior side 130 and an inferior side 140.


Reference is also made to directions or axes that are relative to the implant itself, rather than to its intended orientation with regards to the body. For example, the term “distal” refers to a part that is located further from a center of an implant, while the term “proximal” refers to a part that is located closer to the center of the implant. As used herein, the “center of the implant” could be the center of mass and/or a central plane and/or another centrally located reference surface.


An implant may also be associated with various axes. Referring to FIG. 4, implant 100 may be associated with a longitudinal axis 120 that extends along the longest dimension of implant 100 between first lateral side 114 and second lateral side 116. Additionally, implant 100 may be associated with a posterior-anterior axis 122 (also referred to as a “widthwise axis”) that extends along the widthwise dimension of implant 100, between posterior side 112 and anterior side 110. Moreover, implant 100 may be associated with a vertical axis 124 that extends along the thickness dimension of implant 100 and which is generally perpendicular to both longitudinal axis 120 and posterior-anterior axis 122.


An implant may also be associated with various reference planes or surfaces. As used herein, the term “median plane” refers to a vertical plane which passes from the anterior side to the posterior side of the implant, dividing the implant into right and left halves, or lateral halves. As used herein, the term “transverse plane” refers to a horizontal plane located in the center of the implant that divides the implant into superior and inferior halves. As used herein, the term “coronal plane” refers to a vertical plane located in the center of the implant that divides the implant into anterior and posterior halves. In some embodiments, the implant is symmetric or substantially symmetric about two planes, such as the median and the transverse plane.



FIG. 5 is a schematic isometric exploded view of implant 100 according to an embodiment. Referring to FIGS. 4-5, implant 100 is comprised of a body 200 and a cover 220, which together may be referred to as a housing 201 of implant 100. In some embodiments, a body and cover may be integrally formed. In other embodiments, a body and cover may be separate pieces that are joined by one or more fasteners. In the embodiment of FIGS. 4-5, body 200 and cover 220 are separate pieces that are fastened together using additional components of implant 100.


Embodiments of an implant may include provisions for anchoring the implant into adjacent vertebral bodies. In some embodiments, an implant may include one or more anchoring members. In the embodiment of FIGS. 4-5, implant 100 includes a set of blades 240 that facilitate anchoring implant 100 to adjacent vertebral bodies following insertion of implant 100 between the vertebral bodies. Set of blades 240 may be further comprised of first blade 241 and second blade 242. Although the exemplary embodiments described herein include two blades, other embodiments of an implant could include any other number of blades. For example, in another embodiment, three blades could be used. In another embodiment, four blades could be used, with two blades extending from the inferior surface and two blades extending from the superior surface of the implant. Still other embodiments could include five or more blades. In yet another embodiment, a single blade could be used.


An implant with blades can include provisions for moving the blades with respect to a housing of the implant. In some embodiments, an implant includes a blade actuating component that engages with one or more blades to extend and/or retract the blades from the surfaces of the implant. In the embodiment shown in FIGS. 4-5, implant 100 includes a blade actuating component 260. In some embodiments, blade actuating component 260 is coupled to first blade 241 and second blade 242. Moreover, by adjusting the position of blade actuating component 260 within housing 201, first blade 241 and second blade 242 can be retracted into, or extended from, surfaces of implant 100.


An implant can include provisions for locking the position of one or more elements of the implant. In embodiments where the position of a blade actuating component can be changed, an implant can include provisions for locking the actuating component in a given position, thereby also locking one or more blades in a given position, such as through the use of a threaded fastener or other type of securing mechanism. In the embodiment shown in FIG. 5, implant 100 includes locking screw 280. In some embodiments, locking screw 280 can be used to lock blade actuating component 260 in place within implant 100, which ensures first blade 241 and second blade 242 remain in an extended or deployed position, as will be shown further below.


Embodiments can also include one or more fasteners that help attach a body to a cover. In some embodiments, pins, screws, nails, bolts, clips, or any other kinds of fasteners could be used. In the embodiment shown in FIG. 5, implant 100 includes a set of pins 290 that help fasten cover 220 to body 200. In the exemplary embodiments, two pins are used, including first pin 291 and second pin 292. In other embodiments, however, any other number of pins could be used. In another embodiment, a single pin could be used. In still other embodiments, three or more pins could be used.


Body Component


Referring now to FIGS. 6-9, four views are presented of an embodiment of body 200. FIG. 6 is a schematic isometric superior side or top-down isometric view of body 200. FIG. 7 depicts a schematic isometric inferior side or bottom-up isometric view of body 200. FIG. 8 is a schematic posterior or rear side view of body 200. FIG. 9 is a schematic anterior or front side view of body 200. In different embodiments, body 200 may provide the posterior and anterior sides of housing 201, as well as at least one lateral side of housing 201.


In some embodiments, the lateral sides of a body may both have a lattice-like geometry. Various openings or apertures, as will be discussed below, can help reduce the overall weight of the implant, and/or decrease manufacturing costs associated with material usage. Furthermore, in some cases, openings can increase the surface area available throughout body 200, and facilitate the application of bone growth promoting materials to the implant, and/or facilitate the coupling of the implant with the insertion tool, as will be discussed further below. In some other embodiments, the lateral sides could be configured as solid walls with one or more openings. Furthermore, by providing openings in the housing of the implant, there can be improved visual clarity regarding the degree or extent of blade deployment.


In the exemplary embodiment shown in FIGS. 6-9, body 200 has a generally oval cross-sectional shape in a horizontal plane. Furthermore, each of superior side 130 and inferior side 140 include at least one through-hole opening. For example, in FIGS. 6 and 7, it can be seen that implant 100 includes a first opening 610 and a second opening 612. Each of first opening 610 and second opening 612 extend continuously through the thickness of implant 100 from superior side 130 to inferior side 140 in a direction substantially aligned with vertical axis 124. While the openings can vary in size, shape, and dimension in different embodiments, in one embodiment both first opening 610 and second opening 612 each have a generally half-circle or semi-circle cross-sectional shape along the horizontal plane.


In addition, as shown in FIGS. 8 and 9, posterior side 112 and anterior side 110 of body 200 have a generally oblong rectangular shape. Furthermore, in FIGS. 4, 6 and 8-9, it can be seen that a sidewall 630 extends around the majority of perimeter of body 200, extending between superior side 130 to inferior side 140 in a direction substantially aligned with vertical axis 124, forming a periphery that surrounds or defines a majority of the outer surface of the implant. In some embodiments, first lateral side 114 and second lateral side 116 are substantially similar (i.e., can include substantially similar structural features), though in other embodiments, each side can include variations. There may be additional openings formed in implant 100 in some embodiments. In different embodiments, sidewall 630 can include a plurality of side openings or apertures, though in other embodiments, sidewall 630 can be substantially continuous or solid.


Referring back to FIG. 4, it can be seen that first lateral side 114 includes a first aperture 480, a second aperture 482, a third aperture 484, a fourth aperture 486, a fifth aperture 488, and a sixth aperture 490. Each aperture can differ in shape in some embodiments. For example, first aperture 480 has a substantially oblong rectangular shape, second aperture 482 has a five-sided or substantially pentagonal shape, third aperture 484 and fifth aperture 488 each have a four-sided or substantially trapezoidal shape, fourth aperture 486 has a substantially round shape, and sixth aperture 490 has a six-sided or substantially hexagonal shape. In other embodiments, second lateral side 116 can include a fewer or greater number of apertures. It should be understood that second lateral side 116 can also include a plurality of apertures disposed in a similar arrangement as first lateral side 114 in some embodiments. The shapes of the various openings are configured to permit the implant body to be manufactured in the Direct Metal Laser Sintering (DMLS) process, as well as to provide support to the inferior and superior load bearing surfaces.


As shown in FIG. 6, in one embodiment, anterior side 110 of body 200 includes guide opening 222. Guide opening 222 extends through the thickness of sidewall 630 in a direction substantially aligned with posterior-anterior axis 122. Guide opening 222 includes a chamber portion (“chamber”) 492 and a hollow grooved portion (the hollow grooved portion will be discussed further below with respect to FIGS. 31 and 32). Chamber 492 can be understood to be connected with the grooved portion such that some components can pass from chamber 492 into the grooved portion (or vice versa).


In some embodiments, as will be discussed further below and is shown generally in FIG. 4, a portion of blade actuating component 260 can be configured to extend through or be received by the chamber portion. In other words, in some embodiments, the chamber portion can be sized and dimensioned to fit or extend closely around a portion of blade actuating component 260. In FIG. 6, it can be seen that chamber 492 comprises a generally oblong four-sided opening. In one embodiment, chamber 492 has a substantially oblong square or rectangular cross-sectional shape in a vertical plane. In FIG. 6, chamber 492 extends between an outwardly-facing or distally oriented surface 685 of sidewall 630 and an inwardly-facing or proximally oriented surface 695 of sidewall 630. As chamber 492 approaches proximally oriented surface 695, there may be additional recessed regions or diagonal slots 632 which expand the size of guide opening 222, and can be configured to snugly receive or fit various portions of blade actuating component 260, as will be discussed further below. Furthermore, it can be understood that the cross-sectional shape of the chamber portion is configured to prevent rotation of the driven shaft portion when the drive shaft portion is inserted into the chamber portion.


Body 200 can also include additional reinforcement structures. For example, as shown in FIGS. 6 and 7, body 200 includes a first inner sidewall 634 extending in a direction substantially aligned with posterior-anterior axis 122 and a second inner sidewall 636 extending in a direction substantially aligned with posterior-anterior axis 122. First inner sidewall 634 and second inner sidewall 636 can be substantially parallel in one embodiment. As noted above, different portions of body 200 can include recessed areas or apertures. In one embodiment, shown best in FIG. 7, first inner sidewall 634 and/or second inner sidewall 636 include a plurality of apertures 645.


Furthermore, in some embodiments, first inner sidewall 634 and second inner sidewall 636 can help define or bound a central hollow region 638 in body 200. Central hollow region 638 can extend through the thickness of body 200. Central hollow region 638 can be configured to receive the blades and the blade actuating component, as will be discussed further below. In FIGS. 6 and 7, it can be seen that central hollow region 638 includes a main opening 640 and a posterior opening 642, where main opening 640 is connected with a posterior opening 642 such that some components can pass from main opening 640 into posterior opening 642. Main opening 640 is located toward a center or middle portion of the body, and posterior opening 642 is located along the posterior periphery of the body. In one embodiment, posterior opening 642 is significantly narrower in width across the horizontal plane relative to the width associated with main opening 640.


In different embodiments, posterior opening 642 can be disposed between a first end portion 696 and a second end portion 698 that are associated with posterior side 112 of body 200. Furthermore, in some embodiments, each end portion can include a recessed region. In FIG. 6, a first posterior recess 692 is formed within a portion of first end portion 696 and a second posterior recess 694 is formed within a portion of second end portion 698. As will be discussed below with respect to FIGS. 20 and 21, first posterior recess 692 and second posterior recess 694 can be configured to receive a cover.


First end portion 696 and a second end portion 698 can be substantially similar in some embodiments. In one embodiment, first end portion 696 and a second end portion 698 are mirror-images of one another relative to a central posterior-anterior axis or midline. In some embodiments, first posterior recess 692 and second posterior recess 694 are sized and dimensioned to snugly receive a rearward cover or cap that extends between or bridges together first end portion 696 and second end portion 698 of body 200, providing a substantially continuous outer periphery of the implant. In addition, in some embodiments, either or both of first end portion 696 and second end portion 698 can include pin holes (shown in FIG. 5 as pin holes 202), which can be used to help secure the cover to the posterior side of body 200 (see FIGS. 20-21).


The configuration of body 200 shown for the embodiment of FIGS. 6-9 may facilitate the manufacturing process in different embodiments. In particular, this configuration may permit 3D Printing via laser or electron beam with minimal support structures by forming a unitary piece with a plurality of openings. This design may also help to improve visibility of adjacent bony anatomy under X-ray fluoroscopy while still providing sufficient structural support and rigidity to withstand all testing requirements and the clinical loading of an implant. Other embodiments, not pictured in the figures, include round or rectangular openings in otherwise solid geometry of the anterior, posterior, or lateral sides.


Embodiments can also include one or more blade retaining portions. A blade retaining portion may receive any part of a blade, including one or more edges and/or faces of the blade. In one embodiment, a body includes blade retaining portions to receive the anterior and posterior edges of each blade. As seen in FIG. 6, body 200 includes a first blade retaining portion 600 positioned toward anterior side 110 of first inner sidewall 634 and a second blade retaining portion 602 positioned toward posterior side 112 of first inner sidewall 634. Thus, each blade retaining portion is formed in an outer perimeter of a lateral side of main opening 640 of central hollow region 638. First blade retaining portion 600 comprises a first blade retaining channel extending through the depth of body 200 that is configured to receive an anterior edge of the first blade (see FIG. 13). Likewise, second blade retaining portion 602 comprises a second blade retaining channel extending through the depth of body 200 that is configured to receive a posterior edge of the first blade (see FIG. 13).


In some embodiments, one or more channels can be oriented in a direction that is substantially diagonal relative to the horizontal plane. In one embodiment, a channel can be oriented approximately 45 degrees relative to the horizontal plane. In other embodiments, a channel can be oriented vertically (approximately 90 degrees relative to the horizontal plane) or can be oriented between 30 degrees and 90 degrees relative to the horizontal plane. The orientation of a channel can be configured to correspond to the orientation of the anterior edges and/or posterior edges of a blade in some embodiments.


Body 200 also includes third blade retaining portion 604 and fourth retaining portion 606 for receiving the anterior and posterior edges of the second blade. This configuration may help maximize available bone graft volume within the implant since the lateral edges of the blades serve as tracks for translation. Specifically, this limits the need for additional track members on the blade that would take up additional volume in the implant. Furthermore, the arrangement of the retaining channels and the associated blade edges results in most of the volume of the retaining channels being filled by the blade edges in the retracted position, which helps prevent any graft material or BGPM (details on the effect and use of bone growth promoting material will be discussed further below) from entering the retaining channels and inhibiting normal blade travel.


Blades and Blade Actuating Component



FIG. 10 is an isometric side view of an embodiment of blade actuating component 260. A front or anterior side view of blade actuating component 260 is also shown in FIG. 11, and a lateral side view of blade actuating component 260 is depicted in FIG. 12. Referring to FIGS. 10-12, blade actuating component 260 may include a driven shaft portion 320 and a blade engaging portion 322. Driven shaft portion 320 further includes a driven end 262 along the anterior-most end of driven shaft portion 320.


In some embodiments, driven end 262 can include one or more engaging features. For example, driven shaft portion 320 can include a threaded opening 267 that is accessible from driven end 262, as best seen in FIG. 10. In some embodiments, threaded opening 267 may receive a tool with a corresponding threaded tip. With this arrangement, driven end 262 can be temporarily mated with the end of a tool (see FIG. 37) used to impact blade actuating component 260 and drive the set of blades into adjacent vertebrae. This may help keep both the driving tool and driven end 262 aligned during the impact, as well as reduce the tendency of the driving tool to slip with respect to driven end 262. Using mating features also allows driven end 262 to be more easily “pulled” distally from implant 100, which can be used to retract the blades, should it be necessary to remove the implant or re-position the blades.


In addition, driven shaft portion 320 can be substantially elongated and/or narrow relative to blade engaging portion 322. For example, in FIGS. 10 and 12, driven shaft portion 320 is seen to comprise a substantially elongated rectangular prism. In other words, driven shaft portion 320 has a substantially rounded rectangular cross-sectional shape in the vertical plane. Furthermore, as best seen in FIG. 12, blade engaging portion 322 has a greater width in the direction aligned with vertical axis 124, and includes a generally rectangular shape with a U-shaped or wrench shaped posterior end. The size and shape of blade actuating component 260 allows driven shaft portion 320 to smoothly insert into the guide opening formed in of the body (see FIG. 6) while blade engaging portion 322 is shaped and sized to be positioned in the central opening of the body (see FIG. 7) and configured to receive the blade set.


Furthermore, as will be discussed further below with respect to FIGS. 20 and 21, blade actuating component 260 includes provisions for securing or receiving a portion of the cover within the implant. For example, in FIGS. 10 and 12, blade actuating component 260 includes an actuating posterior end 1200, which includes a receiving portion 1210. Receiving portion 1210 can be sized and dimensioned to receive, fit, or be disposed around a portion of the cover in some embodiments. In one embodiment, receiving portion 1210 comprises a mouth 1220 with two prongs that are spaced apart from one another along vertical axis 124. In some cases, the two prongs can be spaced apart by a width that is substantially similar to the thickness of the cover.


A blade actuating component can include provisions for coupling with one or more blades. In some embodiments, a blade actuating component can include one or more channels. In the exemplary embodiment of FIGS. 10 and 11, blade engaging portion 322 includes a first channel 350 and a second channel 352. First channel 350 may be disposed in a first side surface 334 of blade actuating component 260 while second channel 352 may be disposed in a second side surface 336 of blade actuating component 260.


In addition, referring to FIG. 11, it can be seen that blade engaging portion 322 is oriented diagonally with respect to vertical axis 124. In other words, a superior end 342 of blade engaging portion 322 is offset with respect to an inferior end 344, such that the two ends are not aligned relative to vertical axis 124 when viewed from the anterior side of the component. In some embodiments, this can allow first channel 350 and second channel 352 to be approximately aligned in the vertical direction.



FIG. 13 is a schematic isometric view of a distal face 408 of first blade 241, FIG. 14 is a schematic isometric view of a proximal face 410 of first blade 241, and FIG. 15 depicts an inferior side 1330 of first blade 241. First blade 241, or simply blade 241, includes an outer edge 400 associated with inferior side 1330 of blade 241, an inner edge 402 associated with a superior side 1340, an anterior edge 404 and a posterior edge 406. These edges bind distal face 408 (i.e., a face oriented in the outwardly-facing or distal direction) and proximal face 410 (i.e., a face oriented in the inwardly-facing or proximal direction).


In different embodiments, the geometry of a blade could vary. In some embodiments, a blade could have a substantially planar geometry such that the distal face and the proximal face of the blade are each parallel with a common plane, as best shown in FIG. 15. In other embodiments, a blade could be configured with one or more bends. In some embodiments, a blade can have a channel-like geometry (ex. “C”-shaped or “S”-shaped). In the embodiment shown in FIG. 15, blade 241 has a U-shaped geometry with flanges. In particular, blade 241 a first channel portion 420, a second channel portion 422 and a third channel portion 424. Here, the first channel portion 420 is angled with respect to second channel portion 422 at a first bend 430. Likewise, third channel portion 424 is angled with respect to second channel portion 422 at second bend 432. Additionally, blade 241 includes a first flange 440 extending from first channel portion 420 at a third bend 434. Blade 241 also includes a second flange 442 extending from third channel portion 424 at a fourth bend 436. This geometry for blade 241 helps provide optimal strength for blade 241 compared to other planar blades of a similar size and thickness, and allowing for greater graft volume.


Furthermore, in some embodiments, blade 241 can include provisions for increasing the support or structural strength of blade 241. In one embodiment, blade 241 includes a bridge portion 1350 that is disposed or formed on distal face 408. Referring to FIG. 13, bridge portion 1350 extends between third bend 434 and fourth bend 436. Bridge portion 1350 can be configured to increase the structural support of blade 2412. In different embodiments, bridge portion 1350 can include features that provide a truss, brace, buttress, strut, joist, or other type of reinforcement to the curved or undulating structure of blade 241. In one embodiment, bridge portion 1350 is disposed nearer to the inner edge relative to the outer edge, such that bridge portion 1350 is offset relative to the distal face of the blade.


In some embodiments, bridge portion 1350 includes a relatively wide U-shaped or curved V-shaped outer sidewall 1370. In FIG. 13, outer sidewall 1370 extends between third bend 434 and fourth bend 436. Furthermore, bridge portion 1350 can have an inner sidewall (disposed on the opposite side of the bridge portion relative to the outer sidewall) that is disposed flush or continuously against the distal surfaces of first channel portion 420, second channel portion 422, and third channel portion 424, represented in FIG. 13 by a U-shaped edge 1380. In one embodiment, the U-shape associated with the inner sidewall or edge of bridge portion 1350 is substantially similar to the U-shape geometry of blade 241.


Bridge portion 1350 can also be substantially symmetrical in some embodiments. For example, in FIG. 13, bridge portion 1350 comprises a first triangular prism portion 1310 joined to a second triangular prism portion 1320 by a central curved portion. Each portion can bolster the structure of the blade, and provide resistance against the pressures applied to a blade by external forces during use of the implant. Thus, bridge portion 1350 can improve the ability of blade 241 to resist external pressures and forces and/or help maintain the specific shape of blade 241.


In the exemplary embodiment, the outer edge 400 is a penetrating edge configured to be implanted within an adjacent vertebral body. To maximize penetration, outer edge 400 may be sharpened so that blade 241 has an angled surface 409 adjacent outer edge 400. Moreover, in some embodiments, anterior edge 404 and posterior edge 406 are also sharpened in a similar manner to outer edge 400 and may act as extensions of outer edge 400 to help improve strength and penetration. It can be understood that, in some embodiments, bridge portion 1350 can also serve to help prevent the blades from extending further outward into a vertebrae downward once they reach the desired deployment extension.


A blade can further include provisions for coupling with a blade actuating component. In some embodiments, a blade can include a protruding portion. In some embodiments, the protruding portion can extend away from a face of the blade and may fit within a channel in a blade actuating component. Referring to FIG. 14, blade 241 includes a protruding portion 450 that extends from proximal face 410. Protruding portion 450 may generally be sized and shaped to fit within a channel of the blade actuating component (i.e., first channel 350 shown in FIG. 11). In particular, the cross-sectional shape may fit within a channel of the blade actuating component. In some cases, the cross-sectional width of protruding portion 450 may increase between a proximal portion 452 and a distal portion 454 allowing protruding portion 450 to be interlocked within a channel as discussed in detail below.


A protruding portion may be oriented at an angle on a blade so as to fit with an angled channel in a blade actuating component. In the embodiment of FIG. 14, protruding portion 450 may be angled with respect to inner edge 402 such that the body of blade 241 is vertically oriented within the implant when protruding portion 450 is inserted within the first channel. In other words, the longest dimension of protruding portion 450 may form a protruding angle 459 with inner edge 402.


Although the above discussion is directed to first blade 241, it may be appreciated that similar principles apply for second blade 242. In particular, in some embodiments, second blade 242 may have a substantially identical geometry to first blade 241. Furthermore, while reference is made to a superior side and inferior side with respect to the first blade, it will be understood that, in some embodiments, the orientation of the second blade can differ such that the inner edge is associated with the inferior side and the outer edge is associated with the superior side.


As noted above, each blade may be associated with the blade engaging portion of the blade actuating component. In FIG. 16, an exploded isometric view is shown with blade actuating component 260, first blade 241, and second blade 242, and in FIG. 17, first blade 241 and second blade 242 are assembled within blade actuating component 260. It can be seen that protruding portion 450 of first blade 241 fits into first channel 350. Likewise, protruding portion 455 of second blade 242 fits into second channel 352. Referring to FIGS. 16 and 17, blade engaging portion 322 may comprise a superior surface 330, an inferior surface 332, a first side surface 334, and a second side surface 336. Here, first side surface 334 may be a first lateral side facing surface and second side surface 336 may be a second lateral side facing side surface.


Each channel that is formed in blade engaging portion 322 is seen to extend at an angle between superior surface 330 and inferior surface 332 of blade engaging portion 322. For example, as best seen in FIG. 16, first channel 350 has a first end 354 open along superior surface 330 and a second end 356 open along inferior surface 332. Moreover, first end 354 is disposed further from driven shaft portion 320 than second end 356. Likewise, second channel 352 includes opposing ends on superior surface 330 and inferior surface 332, though in this case the end disposed at superior surface 330 is disposed closer to driven shaft portion 320 than the end disposed at inferior surface 332.


In different embodiments, the angle of each channel could be selected to provide proper blade extension for varying implant sizes. As used herein, the angle of a channel is defined to be the angle formed between the channel and a transverse plane of the blade actuating component. In the embodiment of FIGS. 16 and 17, first channel 350 forms a first angle with transverse plane 370 of blade actuating component 260, while second channel 352 forms a second angle with transverse plane 370. In the exemplary embodiment, the first angle and the second angle are equal to provide balanced reactive forces as the blades are deployed. By configuring the blades and blade actuating component in this manner, each blade is deployed about a centerline (e.g., transverse plane 370) of the blade actuating component, which helps minimize friction and binding loads between these parts during blade deployment. Additionally, the arrangement helps provide balanced reaction forces to reduce insertion effort and friction.


In different embodiments, the angle of each channel could vary. In some embodiments, a channel could be oriented at any angle between 15 and 75 degrees. In other embodiments, a channel could be oriented at any angle between 35 and 65 degrees. Moreover, in some embodiments, the angle of a channel may determine the angle of a protruding portion in a corresponding blade. For example, protruding angle 459 formed between protruding portion 450 and inner edge 402 of blade 241 (see FIG. 14) may be approximately equal to the angle formed between first channel 350 and transverse plane 370. This keeps the outer penetrating edge of blade 241 approximately horizontal so that the degree of penetration does not vary at different sections of the blade.


Furthermore, as seen in FIG. 16, each channel has a cross-sectional shape that facilitates a coupling or fit with a corresponding portion of a blade. As an example, channel 350 has an opening 355 on first side surface 334 with an opening width 390. At a location 357 that is proximal to opening 355, channel 350 has a width 392 that is greater than opening width 390. This provides a cross-sectional shape for channel 350 that allows for a sliding joint with a corresponding part of first blade 241. In the exemplary embodiment, first channel 350 and second channel 352 are configured with dovetail cross-sectional shapes. In other embodiments, however, other various cross-sectional shapes could be used that would facilitate a similar sliding joint connection with a correspondingly shaped part. In other words, in other embodiments, any geometry for a blade and a blade actuating component could be used where the blade and blade actuating component include corresponding mating surfaces of some kind. In addition, in some embodiments, blade engaging portion 322 may be contoured at the superior and inferior surfaces to resist subsidence and allow maximum blade deployment depth. This geometry may also help to keep the blade engaging portion 322 centered between vertebral endplates. As an example, the contouring of superior surface 330 and inferior surface 332 in the present embodiment is best seen in the enlarged cross-sectional view of FIG. 17.


Each channel may be associated with a first channel direction and an opposing second channel direction. For example, as best seen in FIG. 10, first channel 350 may be associated with a first channel direction 460 that is directed towards superior surface 330 along the length of first channel 350. Likewise, first channel 350 includes a second channel direction 462 that is directed towards inferior surface 332 along the length of first channel 350.


With first protruding portion 450 of first blade 241 disposed in first channel 350, first protruding portion 450 can slide in first channel direction 460 or second channel direction 462. As first protruding portion 450 slides in first channel direction 460, first blade 241 moves vertically with respect to blade actuating component 260 such that first blade 241 extends outwardly on a superior side of the implant to a deployed position (see FIGS. 26-27). As first protruding portion 450 slides in second channel direction 462, first blade 241 moves vertically with respect to blade actuating component 260 such that first blade 241 is retracted within housing 201 of implant 100 (see FIG. 28). In a similar manner, second protruding portion 455 of second blade 242 may slide in first and second channel directions of second channel 352 such that second blade 242 can be extended and retracted from implant 100 on an inferior side (see FIGS. 25-28). By using this configuration, blade actuating component 260 propels both blades in opposing directions thereby balancing the reactive loads and minimizing cantilevered loads and friction on the guide bar.


As shown in the cross section of FIG. 17, the fit between each blade and the respective channel in blade actuating component 260 may be configured to resist motion in directions orthogonal to the corresponding channel directions. For example, with first protruding portion 450 inserted within first channel 350, first blade 241 can translate along first channel direction 460 or second channel direction 462, but may not move in a direction 465 that is perpendicular to first channel direction 460 and second channel direction 462 (i.e., blade 241 cannot translate in a direction perpendicular to the length of first channel 350). Specifically, as previously mentioned, the corresponding cross-sectional shapes of first channel 350 and first protruding portion 450 are such that first protruding portion 450 cannot fit through the opening in first channel 350 on first side surface 334 of blade actuating component 260.


In some embodiments, each protruding portion forms a sliding dovetail connection or joint with a corresponding channel. Using dovetail tracks on the blade actuating component and corresponding dovetail features on the posterior and anterior blades allows axial movement along the angle of inclination while preventing disengagement under loads encountered during blade impaction and retraction. For example, in FIG. 17, first protruding portion 450 forms a sliding dovetail joint with first channel 350. Of course, the embodiments are not limited to dovetail joints and other fits/joints where the opening in a channel is smaller than the widest part of a protruding portion of a blade could be used.


It may be appreciated that in other embodiments, the geometry of the interconnecting parts between a blade and a blade actuating component could be reversed. For example, in another embodiment, a blade could comprise one or more channels and a blade actuating component could include corresponding protrusions to fit in the channels. In such embodiments, both the protruding portion of the blade actuating component and the channels in the blades could have corresponding dovetail geometries.


Body and Cover


As discussed above with respect to FIG. 5, embodiments of implant 100 can include a cover 220 that is configured to close or bridge the posterior opening of body 200 and help secure the various components of implant 100 together. FIG. 18 is a schematic isometric superior-side view of an embodiment of cover 220, and is a schematic isometric inferior-side view of an embodiment of cover 220. Referring to FIGS. 18 and 19, cover 220 includes one or more openings for engaging different parts of implant 100. For example, cover 220 may include a first pin hole 227 and a second pin hole 228 that are configured to receive a first pin and a second pin, respectively (see FIG. 5). Each pin hole can comprise a through-hole that extends from the superior surface to the inferior surface of cover 220, though in other embodiments pin holes can be blind holes. Moreover, first pin hole 227 and second pin hole 228 (shown in FIGS. 18 and 19) of cover 220 may be aligned with corresponding holes in the body, as discussed below.



FIG. 20 is a schematic isometric exploded view of body 200 and cover 220. FIG. 21 is a schematic isometric assembled view of body 200 and cover 220, together forming housing 201 of implant 100. Specifically, in some embodiments, cover 220 can be inserted into the recesses associated with a posterior end 2000 of body 200. In addition, first pin hole 227 and second pin hole 228 shown in FIG. 20 can be aligned with the pin receiving openings of body 200 comprising between two and four through-hole channels in posterior end 2000. In FIG. 20, first end portion 696 includes a third pin hole 2030 in a superior portion of first end portion 696 and a fourth pin hole 2040 in an inferior portion of first end portion 696. Similarly, second end portion 698 includes a fifth pin hole 2050 in a superior portion of second end portion 698 and a sixth pin hole 2060 in an inferior portion of second end portion 698. When cover 220 is received by body 200, as shown in FIG. 21, third pin hole 2030 and the fourth pin hole are aligned with the first pin hole of cover 220, and fifth pin hole 2050 and the sixth pin hole are aligned with the second pin hole of cover 220. Other embodiments may have a fewer or greater number of pin holes. In some embodiments, body 200 may only include third pin hole 2030 and fifth pin hole 2050, for example. Once cover 220 has been inserted into body 200, first pin 291 and second pin 292 (see FIG. 20) can be inserted into the two sets of pin holes to fasten or secure the body to the cover.


Insertion Position and Deployed Position of Implant


As noted above, the embodiments described herein provide an implant that can move from a first position (the “insertion position”), which allows the implant to maintain a low profile, to a second position (the “impaction position” or the “deployed position”), that deploys the blades and inserts them into the proximal superior and inferior vertebral bodies. While the implant is in the first (insertion) position, the blades of the device may be retracted within the body of the implant (i.e., the blades may themselves be in a “retracted position”). In the second (deployed) position of the implant, the blades extend superiorly (or cranially) or inferiorly (or caudally) beyond the implant and into the vertebral bodies to prevent the implant from moving out of position over time. Thus, the blades themselves may be said to be in an “extended position” or “deployed position”. When the blades are deployed, the implant resists left to right rotation and resists flexion and/or extension. It may be appreciated that although the blades may approximately move in vertical directions (i.e., the superior and inferior directions), the actual direction of travel may vary from one embodiment to another. For example, in some embodiments the blades may be slightly angled within the implant and may deploy at slight angles relative to a vertical direction (or to the inferior/superior directions).



FIGS. 4, 21, and 22-24 illustrate several views of implant 100 in different operating modes or operating positions. Specifically, FIG. 4 is a schematic isometric anterior side view of implant 100 in an insertion position. FIG. 21 is a schematic isometric posterior side view of implant 100 in the same insertion position of FIG. 4. Referring to FIG. 4, in the insertion position, driven end 262 of blade actuating component 260 may be disposed distal to the chamber portion of body 200 (i.e., a portion of blade actuating component 260 is disposed or extends through the chamber portion). With implant 100 in the insertion position, first blade 241 and second blade 242 are retracted within housing 201. Thus, as best seen in FIGS. 4 and 21, neither first blade 241 or second blade 242 extend outwardly (distally) from superior side 130 or inferior side 140, respectively, of implant 100. In this insertion position, implant 100 has a compact profile and can be more easily maneuvered into place in the excised disc space between adjacent vertebrae.



FIG. 22 is a schematic isometric view of implant 100 in a deployed position. FIG. 23 is a schematic anterior side view of implant 100 in the same deployed position of FIG. 22. FIG. 24 is a schematic lateral side view of implant 100 in the same deployed position of FIG. 23. Referring to FIG. 23, in the deployed position, driven end 262 of blade actuating component 260 may be disposed proximally to an anterior opening 2250 formed in the outer periphery of body 200 (i.e., the entirety of blade actuating component 260 is disposed within implant 100). With implant 100 in the deployed position, first blade 241 and second blade 242 are extended outwards from superior side 130 and inferior side 140, respectively, so as to be inserted into adjacent vertebral bodies. Furthermore, each blade remains positioned in the central hollow region of the body in both the retracted and extended positions. For example, an inner edge of each blade is disposed in a central hollow region of the housing in the retracted position, and the inner edge of the blade remains in the central hollow region in the extended position.


In some embodiments, one or more blades could be deployed at a slight angle, relative to the normal directions on the superior and inferior surfaces of the implant. In some embodiments, one or more blades could be oriented at an angle between 0 and 30 degrees. In other embodiments, one or more blades could be oriented at an angle that is greater than 30 degrees. In the exemplary embodiment shown in FIG. 23, first blade 241 and second blade 242 are both oriented at a slight angle from normal axis 251. Specifically, first blade 241 forms a first angle 250 with normal axis 251 and second blade 242 forms a second angle 252 with normal axis 251. In one embodiment, first angle 250 and second angle 252 are both approximately 10 degrees. Angling the blades in this way may help keep first blade 241 and second blade 242 approximately centered in the adjacent vertebrae upon deployment. In an exemplary embodiment, the common anterior implant blade angle is chosen to keep the blades close to the centerline of the vertebral body to minimize rotational loads on the vertebral bodies during blade deployment and also to provide an optional cover plate screw clearance. In addition, it can be seen in FIG. 23 that the outer edge of each blade is positioned toward a central region of the implant when the blade is deployed, such that the outer edge is positioned centrally relative to the housing in the extended position.


The extension of each blade could vary in different embodiments. In some embodiments, a blade could extend outwardly by a length between 0 and 100% of the depth of an implant. In still other embodiments, combined blade height could extend outwardly by a length between 100 and 130% of the depth of an implant. In the exemplary embodiment shown in FIGS. 22-24, first blade 241 and second blade 242 combined may be coverable of extending outwardly from implant 100 by an amount equal to 110% of the depth of implant 100. This can be done while still keeping the blades fully retracted within implant 100 since the blades are guided by two robust parallel tracks in body 200 and also by angled cross channels in blade actuating component 260, thus constraining all six axes of motion. In other embodiments, the combined blade height at deployment could be less than 100%. In one embodiment, the implant could be designed so that the combined blade height is less than 10 mm to reduce the risk of fracturing the adjacent vertebral bodies. In another embodiment, the implant has a combined blade height of 6 mm or less.


Furthermore, as disclosed in the “Implant With Deployable Blades” application, in some embodiments, implant 100 can use a three-point attachment configuration for each of first blade 241 and second blade 242. Specifically, each blade is received along its lateral edges by two blade retaining portions, and also coupled to blade actuating component 260 using the dovetail connection described above. In other words, anterior edge 404 of first blade 241 is received within the first blade retaining channel of first blade retaining portion 600. Posterior edge 406 of first blade 241 is received within a second retaining channel of second blade retaining portion 602. Moreover, distal face 408 of first blade 241 remains unattached to any other elements of implant 100. Not only does first blade 241 remain unattached along distal face 408, but the entirety of distal face 408 between anterior edge 404 and posterior edge 406 is spaced apart from (i.e., not in contact with) all other elements of implant 100. Further, second blade 242 is likewise attached at its lateral edges to corresponding blade retaining portions and also coupled to blade actuating component 260 using a sliding dovetail connection. Thus, first blade 241 and second blade 242 are held in implant 100 using a three-point attachment configuration that may limit unwanted friction on first blade 241 and second blade 242 during impaction. It may be appreciated that the fit between each blade and each blade retaining channel may provide sufficient clearance to allow for translation of the blades along the retaining channels. In other words, the fit may not be so tight as to impede movement of the lateral edges within the retaining channels.


In different embodiments, the cross-sectional geometry of channels in one or more blade retaining portions could vary. In some embodiments, the cross-sectional geometry could be rounded. In the embodiments disclosed herein, first blade retaining portion 600 (see FIG. 22) has a rectangular blade retaining channel. This rectangular geometry for the blade tracks or channels and tolerance allows for precise axial travel without binding from actuation ramp angular variations. In some embodiments, the posterior edge and anterior edge of each blade may remain in the tracks or channels of each blade retaining portion while the blades are retracted to prevent bone graft material from restricting free deployment of the blades.


Using an interlocking joint, such as a dovetail sliding joint, to connect the blades and a blade actuating component helps prevent the blades from decoupling from the blade actuating component during impact. Additionally, with an interlocking joint the blade actuating component can be used to retract the blades.



FIGS. 25-28 illustrate several schematic views of implant 100 during an impact sequence (FIGS. 25-27) as well as during a step of retracting the blades (FIG. 28). In FIGS. 25-28, housing 201 of implant 100 is shown in phantom to better show blade actuating component 260, first blade 241 and second blade 242. Also, each of FIGS. 25-28 include cross-sectional views of a section of blade actuating component 260, first blade 241 and second blade 242 to better illustrate the coupling between these parts during actuation.


In FIG. 25, implant 100 is in the insertion position, with first blade 241 and second blade 242 fully retracted within housing 201. Next, as seen in FIG. 26, an impacting force 700 is applied to driven end 262 of blade actuating component 260. As blade actuating component 260 is translated towards posterior side 112 of implant 100, blade actuating component 260 applies forces to first blade 241 and second blade 242 along first channel 350 and second channel 352, respectively. Specifically, the orientation of first channel 350 is such that first blade 241 is forced towards the inferior side of implant 100. Likewise, the orientation of second channel 352 is such that second blade 242 is forced towards the superior side of implant 100. However, in other embodiments, the channel orientations can be switched such that first blade 241 is forced towards the inferior side of implant 100 and second blade 242 is forced towards the superior side of implant 100.


Furthermore, the interlocking connection between first protruding portion 450 and first channel 350 (as well as between second protruding portion 455 and second channel 352) means that both blades remain coupled to the motion of blade actuating component 260 at all times. It should be noted that since both blades are restricted from moving in a longitudinal direction, the resulting motion of each blade is purely vertical. Moreover, using the dovetail shaped protruding portions for each blade means the protruding portions are both lifting at the center line to limit any cocking force or rotational moments that could result in increased (friction) resistance to motion or binding of these moving parts.


Using this configuration, the forces deploying the blades are balanced through the blade actuating component 260 in order to minimize friction and binding between driven shaft portion 320 and the guide opening in body 200 (see FIG. 6), which helps to guide blade actuating component 260 and keep its motion restricted to directions parallel to the longitudinal axis (see FIG. 2).


In FIG. 27, implant 100 has been placed in the fully deployed position, with both first blade 241 and second blade 242 fully extended from implant 100. As seen in the cross-sectional view, both first blade 241 and second blade 242 remain coupled with blade actuating component 260 when implant 100 is in the fully deployed position. Because of this coupling, the motion of blade actuating component 260 can be reversed to retract first blade 241 and second blade 242, as shown in FIG. 28.


It may be appreciated that in some embodiments a blade actuating component (e.g., blade actuating component 260) may function to support adjacent vertebral bodies. This is can be accomplished by using a blade actuating component with a height similar to the height of the outer support structure so that the superior and inferior surfaces of the blade actuating component may come into contact with the vertebral bodies following implantation. Since the blade actuating component functions as a load bearing structure within the implant, this may free up additional space in the implant otherwise occupied by additional support structures, thereby increasing the internal volume available for bone graft or BGPMs.


Referring to FIG. 28, driven end 262 of blade actuating component 260 may be pulled in an opposing direction to the motion shown in FIG. 26. For example, in some embodiments a delivery tool can be coupled to driven end 262 using a threaded connector. Then, as the tip of the delivery tool is retracted a retracting or pulling force 710 may be applied to drive end 262. As blade actuating component 260 (and specifically, blade engaging portion 322) is pulled towards anterior side 110 of implant 100, blade actuating component 260 applies forces to first blade 241 and second blade 242 along first channel 350 and second channel 352, respectively. Specifically, the orientation of first channel 350 is such that first blade 241 is forced towards the superior side of implant 100. Likewise, the orientation of second channel 352 is such that second blade 242 is forced towards the inferior side of implant 100. Although not shown, applying sufficient force at driven end 262 may result in full retraction of first blade 241 and second blade 242 so that implant 100 is returned to the insertion position shown in FIG. 25.


As noted above, body 200 may include guide opening 222 that receives a portion of blade actuating component 260. When the implant is in the deployed position, the driven shaft portion can be disposed securely in the chamber portion. In some embodiments, the chamber portion of guide opening 222 may have a shape that matches the cross-sectional shape of a driven shaft portion of a blade actuating component. In some embodiments, both the chamber portion and the driven shaft portion of the blade actuating component have rectangular cross-sectional shapes (see FIGS. 9 and 11). This configuration may allow axial motion, but control rotational and angular loads that could result during blade impaction.


Locking Screw



FIGS. 29 and 30 illustrate two schematic views of locking screw 280, according to an embodiment. Locking screw 280 can be a type of threaded fastener in some embodiments. In FIG. 29, locking screw 280 includes a flanged head 282 with a threaded segment portion 284 and further includes a substantially smooth and elongated body portion 288. Threaded segment portion 284 is sized and dimensioned to engage with the grooved portion of the body (see FIG. 33 below). Flanged head 282 can also include a receiving recess 2900 which can engage with a driving tool in order to secure the locking screw within the implant. Thus, although body portion 288 is disposed within threaded opening of the blade actuating component when the screw lock is secured, body portion 288 need not engage or lock with the threading associated with the threaded opening.


Implant 100 can include provisions for securing the implant 100 in the deployed position. Referring to the exploded isometric view of FIG. 31, guide opening 222 can include a grooved portion 3100 that is formed directly adjacent to the chamber portion. Grooved portion 3100 can have a round cross-sectional shape in the vertical plane, and has a wider diameter relative to the diameter or width of the chamber portion. The diameter of grooved portion 3100 can be configured to mate with the diameter of the flanged head. In one embodiment, grooved portion 3100 is disposed directly adjacent to the outermost anterior periphery of guide opening 222. As locking screw 280 is inserted into the anterior side of guide opening 222 (see FIG. 32), threaded segment portion 284 that extends around flanged head 282 of locking screw 280 can engage with grooved portion 3100, securing locking screw 280 to body 200. When in this position, body portion 288 of locking screw 280 can also be disposed through the passageway of threaded opening 267 of blade actuating component 260. As shown best in the partial cross-sectional view of FIG. 32, when implant 100 is in the deployed position, a portion of driven shaft portion 320 is disposed within chamber 492 of guide opening 222, primarily comprising the portion of driven shaft portion 320 that includes threaded opening 267. Furthermore, flanged head 282 of locking screw 280 extends from anterior opening 2250 through grooved portion 3100, and body portion 288 of locking screw 280 extends through threaded opening 267 of driven shaft portion 320. Flanged head 282 is prevented from moving further into guide opening 222 because of the larger diameter of flanged head 282 relative to body portion 288. Thus, it can be understood that the insertion of the implant and the deployment of the blades of the implant occur through the engagement of an insertion tool within only a single guide opening 222, improving surgical efficiency and safety.


Alternate Blade Actuating Component


In different embodiments, an implant can utilize different types of components to provide the features and functions described herein. In some embodiments, the features of blade actuating component can be adjusted in order to facilitate the use of implant with a variety of surgical requirements. For example, in some embodiments, an alternate embodiment of a second blade actuating component (“second actuating component”) 3300 can be placed within the housing of the body, as shown in FIG. 33. In FIG. 33, second actuating component 3300 is configured with a receiving portion 3350 with a mouth 3320 that is greater in width than the embodiment of the actuating blade component presented above. Adjustments to the size of a mouth in the receiving portion of a blade actuating component can correspond to changes in the dimensions or shape of a cover, bridge piece, or cap that is used in the implant.


In addition, to allow an implant to withstand varying forces and work with different blade types, the height and/or other dimensions of the blade engaging portion can be increased or decreased. For example, in FIG. 12, blade actuating component 260 has a first maximum height 1230, and in FIG. 33, second actuating component 3300 has a second maximum height 3330. First maximum height 1230 is less than second maximum height 3330, such that blade actuating component 260 can be inserted into a smaller region of the human body. However, when the blades being used must be increased in size, the greater height of second actuating component 3300 provides the structural support to the device. In addition, second actuating component 3300 includes diagonal portions 3340 disposed toward the center of the actuating component that can extend the length of channels 3310 and support additional blade weight. In some embodiments, diagonal portions 3340 are integrally formed with second actuating component 3300. In addition, diagonal portions 3340 can add a curved or sloped interface to the actuating component relative to blade actuating component described earlier (see FIG. 12) in which the intersection between drive shaft portion 320 and blade engaging portion 322 is substantially perpendicular.


In order to provide greater detail with respect to the initial insertion position and the deployed position, FIGS. 34 and 35 provide two cross-sectional views of the implant prior to the application of an impacting force (see FIG. 26) and subsequent to the application of the impacting force. It should be noted that while FIGS. 34 and 35 employ second actuating component 3300, the general operation and transition from insertion to deployment of implant 100 remains substantially the same to the process described above with respect to blade actuating component 260. In FIG. 34, second actuating component 3300 is disposed such that driven end 262 extends distally outward and away from an anterior end 3400 of body 200. The remainder of second actuating component 3300 is positioned such that it is offset relative to the interior space of the implant along posterior-anterior axis 122. In other words, the majority of blade engaging portion 322 is disposed nearer to anterior end 3400 than to posterior end 2000 of body 200 in the insertion position.


However, when an impacting force is applied to driven end 262, the substantial entirety of second actuating component 3300 can be disposed within the internal space of the body. Furthermore, actuating posterior end 1200 can move translationally from the main opening of the central hollow region in body 200 toward the posterior opening. It can be seen that a portion of posterior opening 642 is filled with or bridged by a central portion of cover 220. As actuating posterior end 1200 approaches the posterior opening, receiving portion 1210 comprising the two-pronged mouth shown in FIG. 33 can slide or be positioned above the superior surface and below the inferior surface of cover 220, helping to secure the assembly in place and forming a continuous outer surface.


Furthermore, as noted above, in FIG. 34 it can be seen that threaded opening 267 of driven shaft portion 320 can be configured to receive a threaded driving tool. In addition, as shown in FIG. 35, threaded flanged head 282 of the locking screw engages with grooved portion 3100 formed in the structure of body 200, and the locking screw body is smoothly inserted within the channel provided by threaded opening 267. Driven end 262 can be positioned directly adjacent to the posterior end of grooved portion 3100 when implant 100 is in the deployed position. In other words, once implant 100 is in the deployed position, driven end 262 is disposed such that it is spaced apart from the outer opening formed in body 200 by the region comprising grooved portion 3100.


Insertion Process


As noted above, embodiments of implant 100 can make use of features or structures disclosed in the “Insertion Tool For Implant And Methods of Use” application. In some embodiments, implant 100 can be configured for use with a single tool that can significantly facilitate the implantation process. For example, whether a surgeon approaches the disc space from an anterior approach can be dependent on how comfortable the surgeon is with the anterior approach and operating around the aorta and vena cava. By approaching a patient from the anterior side, there can be a risk of vessel injury, as the aorta and vena cava lie in front of the spine. However, the benefits of added stability and fusion area very often outweigh the risks of the extra surgery, and the process of deployment provided herein can help lower such risks.


In some embodiments, body 200 may include attachment points for an insertion instrument. In FIGS. 36 and 37, a portion of an insertion tool 3600 is shown with implant 100. In FIG. 36, insertion tool 3600 is shown as it holds or grasps implant 100. In FIG. 37, the same view of FIG. 36 is shown in a partial cross-section to reveal the engagement of a threaded driver 3610 in guide opening 222.


Body 200 may include provisions for interacting with insertion tool 3600. For example, as seen in FIG. 37, body 200 may include a first cavity 580 and a second cavity 582 (where first cavity 580 refers to first aperture 480 as identified in FIG. 6). Each of first cavity 580 and second cavity 582 may receive the ends of an insertion tool 3600 to improve the grip of the tool on implant 100 during insertion into (or removal from) between the vertebrae of the spine. Furthermore, the same insertion tool 3600 can be utilized to transition implant 100 from the insertion position to the deployed position. As shown in FIGS. 36 and 37, insertion tool 3600 can be used to grasp the implant body. While the implant body is grasped by two gripping jaws 3620, the blade actuating component can be controlled and/or driven by threaded driver 3610. This arrangement can maintain the blades in a retracted position during implant insertion and transfers the impact loads from the surgeon when the threaded cover is removed from the proximal end. Thus, the insertion step, deployment step, and locking screw insertion step can occur through the use of a single tool, and through interaction primarily with only the anterior facing side of the implant. Furthermore, as blade actuating component is pushed inward or outward, there is rotation associated with the threaded driver. The use of insertion tool 3600 and the single guide opening 222 allows the rotation to be generally enclosed or shielded within the jaws of the insertion tool. This process can serve to reduce the risks associated with the insertion of various foreign objects into the patient.


Implant Dimensions


In different embodiments, the size of an implant could vary. In some embodiments, an implant could have any length. Embodiments could have lengths ranging from 40 mm to 60 mm. In some cases, a manufacturer could provide multiple implant options with lengths varying between 40 mm and 60 mm in 5 mm increments. In some embodiments, an implant could have any height. Embodiments could have a height ranging from 4 mm to 16 mm. In some cases, a manufacturer could provide implants with heights varying from 4 mm to 16 mm in 2 mm increments. Embodiments could have widths (i.e., size along the posterior-anterior axis) of 18 mm, 22 mm, 26 mm as well as other sizes.


Embodiments can also be constructed with various lordosis angles, that is, angles of incline between the posterior and anterior sides. Embodiments could be configured with lordosis angles of 8, 15 and 20 degrees, for example. In other embodiments, other lordosis angles could be used for an implant. Furthermore, in some embodiments, the blades can be angled to accommodate additional implants or other implanted device in the spine that are located at adjacent levels, fostering stabilization in the patient's system.


Alignment Features


Embodiments may optionally include one or more alignment features. Exemplary alignment features include, but are not limited to, windows for fluoroscopy positioning, windows for blade deployment validation, windows for aligning a blade actuating component with one or more blades, as well as various other kinds of alignment features. Referring to FIG. 4, body 200 of implant 100 includes a central alignment window (referred to as fourth aperture 486 in FIG. 4). Additionally, as shown in FIG. 13, blade 241 includes an alignment window 297. Alignment window 297 may align with the central alignment window when blade 241 is fully retracted. Moreover, blade actuating component 260 includes an actuating alignment window 277, as shown in FIG. 12. Actuating alignment window 277 may align with the implant body center line when the first blade and the second blade are fully deployed or fully retracted. One or more of these windows (i.e., the central alignment window or actuating alignment window 277) may also facilitate fluoroscopy positioning and may be used to confirm blade deployment. For example, in some cases, when the first blade and the second blade are fully deployed, the blades may clear actuating alignment window 277 of blade actuating component 260.


In some embodiments, the dovetail connections can help to more precisely control the blade position in both directions. Some embodiments of the implant may also include one or more stroke limiting stops. For example, there may be two stroke limiting stops formed on blade actuating component 260. These stops may help prevent over travel of blade actuating component 260. Specifically, a stroke limiting stop may contact the internal surfaces of body 200. In other words, the blade actuating component has a limited stroke dictated by the length of its distal portion and the inside depth of the implant, measured from the inside of the implant proximal wall and the inside surface of the cover that is pinned in place.


Materials


The various components of an implant may be fabricated from biocompatible materials suitable for implantation in a human body, including but not limited to, metals (e.g. titanium, titanium alloy, stainless steel, cobalt-chrome, or other metals), synthetic polymers (e.g. PEEK or PEKK), ceramics, and/or their combinations, depending on the particular application and/or preference of a medical practitioner.


Generally, the implant can be formed from any suitable biocompatible, non-degradable material with sufficient strength. Typical materials include, but are not limited to, titanium, biocompatible titanium alloys (e.g. Titanium Aluminides (including gamma Titanium Aluminides), Ti6—Al4—V ELI (ASTM F 136 and ASTM F 3001), or Ti6—Al4—V (ASTM F 1108, ASTM F 1472, and ASTM F 2989) and inert, biocompatible polymers, such as polyether ether ketone (PEEK) (e.g. PEEK-OPTIMA®, Invibio Inc, Zeniva®, Solvay Inc., or others). Optionally, the implant contains a radiopaque marker to facilitate visualization during imaging when constructed of radiolucent biomaterials.


In different embodiments, processes for making an implant can vary. In some embodiments, the entire implant may be manufactured and assembled via traditional and CNC machining, injection-molding, cast or injection molding, insert-molding, co-extrusion, pultrusion, transfer molding, overmolding, compression molding, 3-Dimensional (3-D) printing, dip-coating, spray-coating, powder-coating, porous-coating, milling from a solid stock material and their combinations.


In one embodiment, body 200 may be produced by Additive Manufacturing. Specifically, Direct Metal Laser Sintering (DMLS) using powder Ti-6Al-4V ELI, and then traditional or CNC machined in specific locations to precise dimensions. Moreover, in one embodiment, as shown in FIG. 5, blade actuating component 260, first blade 241, second blade 242, cover 220, pins 290 and locking screw 280 may also be made of a material including titanium.


Implantation


Some embodiments may use a bone growth promoting material, including bone graft or bone graft substitute material. As used herein, a “bone growth promoting material” (BGPM) is any material that helps bone growth. Bone growth promoting materials may include provisions that are freeze dried onto a surface or adhered to the metal through the use of linker molecules or a binder. Examples of bone growth promoting materials are any materials including bone morphogenetic proteins (BMPs), such as BMP-1, BMP-2, BMP-4, BMP-6, and BMP-7. These are hormones that convert stem cells into bone forming cells. Further examples include recombinant human BMPs (rhBMPs), such as rhBMP-2, rhBMP-4, and rhBMP-7. Still further examples include platelet derived growth factor (PDGF), fibroblast growth factor (FGF), collagen, BMP mimetic peptides, as well as RGD peptides. Generally, combinations of these chemicals may also be used. These chemicals can be applied using a sponge, matrix or gel.


Some bone growth promoting materials may also be applied to an implantable prosthesis through the use of a plasma spray or electrochemical techniques. Examples of these materials include, but are not limited to, hydroxyapatite, beta tri-calcium phosphate, calcium sulfate, calcium carbonate, as well as other chemicals.


A bone growth promoting material can include, or may be used in combination with a bone graft or a bone graft substitute. A variety of materials may serve as bone grafts or bone graft substitutes, including autografts (harvested from the iliac crest of the patient's body), allografts, demineralized bone matrix, and various synthetic materials.


Some embodiments may use autograft. Autograft provides the spinal fusion with calcium collagen scaffolding for the new bone to grow on (osteoconduction). Additionally, autograft contains bone-growing cells, mesenchymal stem cells and osteoblast that regenerate bone. Lastly, autograft contains bone-growing proteins, including bone morphogenic proteins (BMPs), to foster new bone growth in the patient.


Bone graft substitutes may comprise synthetic materials including calcium phosphates or hydroxyapatites, stem cell containing products which combine stem cells with one of the other classes of bone graft substitutes, and growth factor containing matrices such as INFUSE® (rhBMP-2-containing bone graft) from Medtronic, Inc.


It should be understood that the provisions listed here are not meant to be an exhaustive list of possible bone growth promoting materials, bone grafts or bone graft substitutes.


In some embodiments, BGPM may be applied to one or more outer surfaces of an implant. In other embodiments, BGPM may be applied to internal volumes within an implant. In still other embodiments, BGPM may be applied to both external surfaces and internally within an implant.


While various embodiments have been described, the description is intended to be exemplary, rather than limiting, and it will be apparent to those of ordinary skill in the art that many more embodiments and implementations are possible that are within the scope of the embodiments. Although many possible combinations of features are shown in the accompanying figures and discussed in this detailed description, many other combinations of the disclosed features are possible. Any feature of any embodiment may be used in combination with, or substituted for, any other feature or element in any other embodiment unless specifically restricted. Therefore, it will be understood that any of the features shown and/or discussed in the present disclosure may be implemented together in any suitable combination. Accordingly, the embodiments are not to be restricted except in light of the attached claims and their equivalents. Also, various modifications and changes may be made within the scope of the attached claims.

Claims
  • 1. An implant, comprising: a housing;a blade having a retracted position in the housing and an extended position where the blade extends outwardly from the housing; anda blade actuating component comprising a driven shaft portion and a blade engaging portion, the driven shaft portion of the blade actuating component having a driven end;wherein the blade actuating component can move the blade between the retracted position and the extended position;wherein the blade engaging portion of the blade actuating component has a substantially U-shaped configuration defined at least in part by a superior surface and an inferior surface;wherein, when the blade is in the extended position, the superior surface of the blade engaging portion of the blade actuating component is substantially flush with a superior surface of the housing, and the inferior surface of the blade engaging portion of the blade actuating component is substantially flush with an inferior surface of the housing; andwherein, when the blade is in the extended position, the driven end of the blade actuating component is disposed inside of the housing.
  • 2. The implant according to claim 1, wherein the superior surface and the inferior surface of the blade actuating component are oriented generally at an angle with respect to one another to align with a lordotic angle of the implant.
  • 3. The implant according to claim 1, wherein the superior surface and the inferior surface of the blade actuating component are disposed internal to an outer envelope of the implant when the blade is in the retracted position.
  • 4. The implant according to claim 1, wherein a distal end of the blade actuating component is flush with an outer posterior surface of the implant when the blade is in the extended position.
  • 5. The implant according to claim 1, wherein the driven end is disposed outside of the housing when the blade is in the retracted position, and wherein the blade transitions from the retracted position to the extended position when a force is applied to the driven end.
  • 6. An implant, comprising: a housing;a blade having a retracted position in the housing and an extended position where the blade extends outwardly from the housing; anda blade actuating component comprising a driven shaft portion and a blade engaging portion, the driven shaft portion of the blade actuating component having a driven end;wherein the blade actuating component can move the blade between the retracted position and the extended position;wherein a posterior side of the housing includes a posterior opening extending between a first end portion of the housing and a second end portion of the housing;wherein the posterior opening of the housing is configured to receive a distal end of the blade actuating component; andwherein, when the blade is in the extended position, the driven end of the blade actuating component is disposed inside of the housing.
  • 7. The implant according to claim 6, wherein the posterior opening is a substantially vertically oriented slot.
  • 8. The implant according to claim 7, wherein the slot extends completely through the posterior side of the housing, such that the housing is discontinuous.
  • 9. The implant according to claim 6, further including a cover configured to be attached to the housing and bridge across the posterior opening.
  • 10. The implant according to claim 9, wherein the posterior side of the housing includes a first recess configured to receive a portion of the cover.
  • 11. The implant according to claim 10, further including a pair of pins securing the cover in the recess of the housing.
  • 12. The implant according to claim 6, wherein the driven end is disposed outside of the housing when the blade is in the retracted position, and wherein the blade transitions from the retracted position to the extended position when a force is applied to the driven end.
US Referenced Citations (511)
Number Name Date Kind
4554914 Kapp et al. Nov 1985 A
4599086 Doty Jul 1986 A
4636217 Ogilvie et al. Jan 1987 A
5443467 Biedermann Aug 1995 A
5522899 Michelson Jun 1996 A
5609635 Michelson Mar 1997 A
5653708 Howland Aug 1997 A
5667508 Errico Sep 1997 A
5683394 Rinner Nov 1997 A
5702391 Lin Dec 1997 A
5776199 Michelson Jul 1998 A
5800500 Sertich Sep 1998 A
5800547 Schaefer et al. Sep 1998 A
5800550 Sertich Sep 1998 A
5989254 Katz Nov 1999 A
6102949 Biedermann et al. Aug 2000 A
6102950 Vaccaro Aug 2000 A
6113601 Tatar Sep 2000 A
6113638 Williams Sep 2000 A
6179873 Zientek Jan 2001 B1
6251140 Marino Jun 2001 B1
6302914 Michelson Oct 2001 B1
6371987 Weiland et al. Apr 2002 B1
6447544 Michelson Sep 2002 B1
6447546 Bramlet Sep 2002 B1
6447547 Michelson Sep 2002 B1
6454805 Baccelli et al. Sep 2002 B1
6478823 Michelson Nov 2002 B1
6520993 James et al. Feb 2003 B2
6527803 Crozet Mar 2003 B1
6565565 Yuan May 2003 B1
6645207 Dixon Nov 2003 B2
6652526 Arafiles Nov 2003 B1
6656181 Dixon Dec 2003 B2
6726720 Ross et al. Apr 2004 B2
6733535 Michelson May 2004 B2
6755829 Bono Jun 2004 B1
6767367 Michelson Jul 2004 B1
6770096 Bolger et al. Aug 2004 B2
6786903 Lin Sep 2004 B2
6800092 Williams Oct 2004 B1
6896677 Lin May 2005 B1
6923830 Michelson Aug 2005 B2
6926737 Jackson Aug 2005 B2
6981975 Michelson Jan 2006 B2
6986771 Paul Jan 2006 B2
6989011 Paul Jan 2006 B2
7066961 Michelson Jun 2006 B2
7081117 Bono Jul 2006 B2
7112206 Michelson Sep 2006 B2
7125426 Moumene Oct 2006 B2
7141051 Janowski Nov 2006 B2
7214243 Taylor May 2007 B2
7217293 Branch, Jr. May 2007 B2
7223289 Trieu May 2007 B2
7264621 Coates Sep 2007 B2
7318839 Malberg et al. Jan 2008 B2
7338491 Baker Mar 2008 B2
7361195 Schwartz et al. Apr 2008 B2
7465317 Malberg et al. Dec 2008 B2
7503924 Lee Mar 2009 B2
7503933 Michelson Mar 2009 B2
7559942 Paul Jul 2009 B2
7569074 Eisermann Aug 2009 B2
7594931 Louis Sep 2009 B2
7594932 Aferzon Sep 2009 B2
7604656 Shluzas Oct 2009 B2
7608095 Yuan Oct 2009 B2
7655046 Dryer Feb 2010 B2
7678137 Butler Mar 2010 B2
7704279 Moskowitz et al. Apr 2010 B2
7727279 Zipnick et al. Jun 2010 B2
7727280 McLuen Jun 2010 B2
7731749 Biedermann Jun 2010 B2
7731751 Butler et al. Jun 2010 B2
7731753 Reo et al. Jun 2010 B2
7744649 Moore Jun 2010 B2
7749274 Razian Jul 2010 B2
7758644 Trieu Jul 2010 B2
7766946 Bailly Aug 2010 B2
7766967 Francis Aug 2010 B2
7771475 Michelson Aug 2010 B2
7776067 Jackson Aug 2010 B2
7780703 Yuan Aug 2010 B2
7789914 Michelson Sep 2010 B2
7811310 Baker Oct 2010 B2
7819901 Yuan Oct 2010 B2
7833252 Justis Nov 2010 B2
7842073 Richelsoph Nov 2010 B2
7846188 Moskowitz et al. Dec 2010 B2
7857857 Kim Dec 2010 B2
7867257 Na Jan 2011 B2
7879099 Zipnick Feb 2011 B2
7883542 Zipnick et al. Feb 2011 B2
7909856 Yuan Mar 2011 B2
7909872 Zipnick et al. Mar 2011 B2
7942903 Moskowitz et al. May 2011 B2
7942910 Doubler May 2011 B2
7942911 Doubler May 2011 B2
7951173 Hammill, Sr. May 2011 B2
7951174 Kwak May 2011 B2
7951180 Moskowitz et al. May 2011 B2
7955359 Matthis Jun 2011 B2
7955363 Richelsoph Jun 2011 B2
7967850 Jackson Jun 2011 B2
7972363 Moskowitz et al. Jul 2011 B2
7972365 Michelson Jul 2011 B2
7981157 Castleman et al. Jul 2011 B2
7998211 Baccelli et al. Aug 2011 B2
8012186 Pham Sep 2011 B2
8021430 Michelson Sep 2011 B2
8034086 Iott Oct 2011 B2
8038702 Yuan Oct 2011 B2
8048124 Chin Nov 2011 B2
8057519 Justis Nov 2011 B2
8062340 Berrevoets Nov 2011 B2
8062374 Markworth et al. Nov 2011 B2
8062375 Glerum Nov 2011 B2
8070812 Keller Dec 2011 B2
8070819 Aferzon Dec 2011 B2
8075590 Janowski Dec 2011 B2
8075599 Johnson Dec 2011 B2
8075603 Hammill, Sr. Dec 2011 B2
8075618 Trieu Dec 2011 B2
8080062 Armstrong et al. Dec 2011 B2
8083796 Raiszadeh et al. Dec 2011 B1
8100972 Bruffey Jan 2012 B1
8105358 Phan Jan 2012 B2
8142479 Hess Mar 2012 B2
8142508 Bruffey Mar 2012 B1
8147556 Louis Apr 2012 B2
8162989 Khalili Apr 2012 B2
8167793 Scott May 2012 B2
8167950 Aferzon et al. May 2012 B2
8182539 Tyber et al. May 2012 B2
8187332 McLuen May 2012 B2
8192495 Simpson et al. Jun 2012 B2
8216313 Moore Jul 2012 B2
8221502 Branch, Jr. Jul 2012 B2
8231676 Trudeau et al. Jul 2012 B2
8241294 Sommerich et al. Aug 2012 B2
8241341 Walker Aug 2012 B2
8241363 Sommerich et al. Aug 2012 B2
8257370 Moskowitz et al. Sep 2012 B2
8257439 Zeegers Sep 2012 B2
8257443 Kamran et al. Sep 2012 B2
8267997 Colleran Sep 2012 B2
8273125 Baccelli et al. Sep 2012 B2
8292958 Bruffey Oct 2012 B1
8328870 Patel Dec 2012 B2
8343219 Allain Jan 2013 B2
8353913 Moskowitz et al. Jan 2013 B2
8361148 Malberg et al. Jan 2013 B2
8366774 Bruffey Feb 2013 B1
8377133 Yuan et al. Feb 2013 B2
8377138 Reo et al. Feb 2013 B2
8388688 Moore Mar 2013 B2
8394145 Weiman Mar 2013 B2
8409285 Keller Apr 2013 B2
8425528 Berry et al. Apr 2013 B2
8435296 Kadaba et al. May 2013 B2
8435301 Gerber et al. May 2013 B2
8444696 Michelson May 2013 B2
8454623 Patel et al. Jun 2013 B2
8460388 Kirwan Jun 2013 B2
8491658 Etminan Jul 2013 B1
8512407 Butler et al. Aug 2013 B2
8512409 Mertens et al. Aug 2013 B1
8518120 Glerum Aug 2013 B2
8523909 Hess Sep 2013 B2
8523946 Swann Sep 2013 B1
8540769 Janowski et al. Sep 2013 B2
8545562 Materna et al. Oct 2013 B1
8545563 Brun et al. Oct 2013 B2
8556979 Glerum Oct 2013 B2
8579982 Michelson Nov 2013 B2
8597353 Kana et al. Dec 2013 B2
8597357 Trudeau et al. Dec 2013 B2
8597360 McLuen et al. Dec 2013 B2
8617245 Brett Dec 2013 B2
8679183 Glerum Mar 2014 B2
8685098 Glerum Apr 2014 B2
8685104 Lee et al. Apr 2014 B2
8696751 Ashley et al. Apr 2014 B2
8698405 Kirwan Apr 2014 B2
8709086 Glerum Apr 2014 B2
8715350 Janowski et al. May 2014 B2
8734516 Moskowitz et al. May 2014 B2
8747444 Moskowitz et al. Jun 2014 B2
8753394 Zipnick et al. Jun 2014 B2
8795335 Abdou et al. Aug 2014 B1
8795367 Zipnick Aug 2014 B2
8795368 Trieu et al. Aug 2014 B2
8814879 Trieu et al. Aug 2014 B2
8828018 Ragab et al. Sep 2014 B2
8845738 Michelson Sep 2014 B2
8858638 Michelson Oct 2014 B2
8864829 Bruffey et al. Oct 2014 B1
8864833 Glerum Oct 2014 B2
8888853 Glerum Nov 2014 B2
8888854 Glerum Nov 2014 B2
8894710 Simpson et al. Nov 2014 B2
8900310 Carlson et al. Dec 2014 B2
8906101 Lee et al. Dec 2014 B2
8920505 Aferzon et al. Dec 2014 B2
8932355 Grotz et al. Jan 2015 B2
8932359 Brett Jan 2015 B2
8940048 Butler et al. Jan 2015 B2
8956413 Ashley et al. Feb 2015 B2
8961605 Zipnick Feb 2015 B2
8968405 Kirwan Mar 2015 B2
8979933 Mshnubholta et al. Mar 2015 B2
8986384 Malberg et al. Mar 2015 B2
8992620 Ashley et al. Mar 2015 B2
8998920 Berry et al. Apr 2015 B2
9005293 Moskowitz et al. Apr 2015 B2
9034041 Wolters et al. May 2015 B2
9039770 Aferzon et al. May 2015 B2
9039771 Glerum May 2015 B2
9107760 Walters Aug 2015 B2
9107761 Lee et al. Aug 2015 B2
9114020 Arginteanu Aug 2015 B2
9119732 Schifano et al. Sep 2015 B2
9155553 Zipnick Oct 2015 B2
9168033 Hess Oct 2015 B2
9168152 Raiszadeh et al. Oct 2015 B2
9186262 McLuen et al. Nov 2015 B2
9198764 Greenberg et al. Dec 2015 B2
9198771 Ciupik Dec 2015 B2
9198774 Pisharodi Dec 2015 B2
9211196 Glerum Dec 2015 B2
9220606 Janowski et al. Dec 2015 B2
9226836 Glerum Jan 2016 B2
9233011 Trudeau et al. Jan 2016 B2
9248028 Gamache Feb 2016 B2
9283085 Greenberg et al. Mar 2016 B2
9283087 Lee et al. Mar 2016 B2
9289308 Marino et al. Mar 2016 B2
9301854 Moskowitz et al. Apr 2016 B2
9351847 Reed et al. May 2016 B2
9364342 Walkenhorst et al. Jun 2016 B2
9370435 Walkenhorst et al. Jun 2016 B2
9375239 Abdou Jun 2016 B2
9463091 Brett Oct 2016 B2
9566163 Suddaby et al. Feb 2017 B2
9675470 Packer et al. Jun 2017 B2
9707100 Duffield et al. Jul 2017 B2
9730802 Harvey Aug 2017 B1
9757164 Hess Sep 2017 B2
20020120272 Yuan Aug 2002 A1
20030004511 Ferree Jan 2003 A1
20030109928 Pasquet Jun 2003 A1
20030125742 Yuan Jul 2003 A1
20030135279 Michelson Jul 2003 A1
20030149484 Michelson Aug 2003 A1
20030187433 Lin Oct 2003 A1
20030187434 Lin Oct 2003 A1
20030187436 Bolger et al. Oct 2003 A1
20040010312 Enayati Jan 2004 A1
20040133280 Trieu Jul 2004 A1
20040153068 Janowski Aug 2004 A1
20040236330 Purcell Nov 2004 A1
20040254644 Taylor Dec 2004 A1
20050027362 Williams et al. Feb 2005 A1
20050033296 Bono Feb 2005 A1
20050033429 Kuo Feb 2005 A1
20050049590 Alleyne Mar 2005 A1
20050060036 Schultz et al. Mar 2005 A1
20050107788 Beaurain May 2005 A1
20050125062 Biedermann et al. Jun 2005 A1
20050131410 Lin Jun 2005 A1
20050143825 Enayati Jun 2005 A1
20050177154 Moumene Aug 2005 A1
20050187548 Butler Aug 2005 A1
20050197760 Kaga Sep 2005 A1
20050228385 Iott Oct 2005 A1
20050283157 Coates Dec 2005 A1
20050288671 Yuan Dec 2005 A1
20060004357 Lee Jan 2006 A1
20060025767 Khalili Feb 2006 A1
20060069436 Sutton et al. Mar 2006 A1
20060095136 McLuen May 2006 A1
20060129149 Iott Jun 2006 A1
20060149241 Richelsoph Jul 2006 A1
20060161152 Ensign Jul 2006 A1
20060217716 Baker Sep 2006 A1
20060241764 Michelson Oct 2006 A1
20060247636 Yuan Nov 2006 A1
20060247776 Kim Nov 2006 A1
20060264933 Baker Nov 2006 A1
20060276789 Jackson Dec 2006 A1
20060276899 Zipnick et al. Dec 2006 A1
20060276901 Zipnick et al. Dec 2006 A1
20060276902 Zipnick et al. Dec 2006 A1
20060282074 Renaud Dec 2006 A1
20060293665 Shluzas Dec 2006 A1
20070050032 Gittings et al. Mar 2007 A1
20070055235 Janowski Mar 2007 A1
20070055241 Matthis Mar 2007 A1
20070088357 Johnson Apr 2007 A1
20070161999 Biedermann Jul 2007 A1
20070162130 Rashbaum Jul 2007 A1
20070213731 Prusmack Sep 2007 A1
20070233078 Justis Oct 2007 A1
20070233080 Na Oct 2007 A1
20070270813 Garamszegi Nov 2007 A1
20070270960 Bonin et al. Nov 2007 A1
20070270961 Ferguson Nov 2007 A1
20070282341 Hes Dec 2007 A1
20080015580 Chao Jan 2008 A1
20080015584 Richelsoph Jan 2008 A1
20080015597 Whipple Jan 2008 A1
20080021562 Huppert Jan 2008 A1
20080027550 Link et al. Jan 2008 A1
20080045953 Garamszegi Feb 2008 A1
20080045955 Berrevoets Feb 2008 A1
20080051901 deVilliers Feb 2008 A1
20080051902 Dwyer Feb 2008 A1
20080133017 Beyar et al. Jun 2008 A1
20080147121 Justis Jun 2008 A1
20080167716 Schwartz et al. Jul 2008 A1
20080177322 Davis Jul 2008 A1
20080177332 Reiley Jul 2008 A1
20080183215 Altarac Jul 2008 A1
20080195159 Kloss Aug 2008 A1
20080200956 Beckwith Aug 2008 A1
20080234686 Beaurain Sep 2008 A1
20080287998 Doubler Nov 2008 A1
20080294203 Kovach Nov 2008 A1
20080312743 Vila Dec 2008 A1
20090030457 Janowski Jan 2009 A1
20090036929 Reglos Feb 2009 A1
20090062866 Jackson Mar 2009 A1
20090082819 Blain Mar 2009 A1
20090164020 Janowski Jun 2009 A1
20090182430 Tyber Jul 2009 A1
20090198241 Phan Aug 2009 A1
20090198245 Phan Aug 2009 A1
20090198338 Phan Aug 2009 A1
20090265007 Colleran Oct 2009 A1
20090270992 Gerber et al. Oct 2009 A1
20090292316 Hess Nov 2009 A1
20090306720 Doubler Dec 2009 A1
20090318974 Yuan Dec 2009 A1
20100004694 Little Jan 2010 A1
20100010547 Beaurain Jan 2010 A1
20100016974 Janowski Jan 2010 A1
20100063552 Chin Mar 2010 A1
20100094352 Iott Apr 2010 A1
20100114318 Gittings et al. May 2010 A1
20100137920 Hammill Jun 2010 A1
20100145455 Simpson et al. Jun 2010 A1
20100145459 McDonough et al. Jun 2010 A1
20100161057 Berry et al. Jun 2010 A1
20100185289 Kirwan Jul 2010 A1
20100185292 Hochschuler et al. Jul 2010 A1
20100191246 Howald et al. Jul 2010 A1
20100198273 Kwak Aug 2010 A1
20100204737 Bae Aug 2010 A1
20100249933 Trieu Sep 2010 A1
20100249935 Slivka et al. Sep 2010 A1
20100268280 Yuan Oct 2010 A1
20100280618 Jodaitis Nov 2010 A1
20100305704 Messerli Dec 2010 A1
20100312279 Gephart Dec 2010 A1
20110009911 Hammill Jan 2011 A1
20110015742 Hong Jan 2011 A1
20110015745 Bucci Jan 2011 A1
20110035007 Patel Feb 2011 A1
20110077739 Rashbaum Mar 2011 A1
20110093074 Glerum et al. Apr 2011 A1
20110098747 Donner Apr 2011 A1
20110106166 Keyer May 2011 A1
20110118840 Huntsman May 2011 A1
20110125196 Quevedo May 2011 A1
20110137349 Moskowitz et al. Jun 2011 A1
20110144701 Altarac Jun 2011 A1
20110160779 Schlaepfer Jun 2011 A1
20110160866 Laurence Jun 2011 A1
20110166655 Michelson Jul 2011 A1
20110196431 Chao Aug 2011 A1
20110196494 Yedlicka et al. Aug 2011 A1
20110202135 Baek et al. Aug 2011 A1
20110208250 Kwak Aug 2011 A1
20110208311 Janowski Aug 2011 A1
20110208312 Moskowitz et al. Aug 2011 A1
20110218579 Jackson Sep 2011 A1
20110230970 Lynn et al. Sep 2011 A1
20110230971 Donner Sep 2011 A1
20110270325 Keyer Nov 2011 A1
20110307016 Reglos Dec 2011 A1
20110313528 Laubert Dec 2011 A1
20120010714 Moskowitz et al. Jan 2012 A1
20120016477 Metcalf et al. Jan 2012 A1
20120029569 Iott Feb 2012 A1
20120029578 Suh Feb 2012 A1
20120029644 Markworth et al. Feb 2012 A1
20120035729 Glerum Feb 2012 A1
20120053693 Zeegers Mar 2012 A1
20120078371 Gamache Mar 2012 A1
20120078373 Gamache et al. Mar 2012 A1
20120095559 Woods et al. Apr 2012 A1
20120109318 Gittings et al. May 2012 A1
20120116466 Dinville May 2012 A1
20120143341 Zipnick Jun 2012 A1
20120150300 Nihalani Jun 2012 A1
20120150304 Glerum Jun 2012 A1
20120150305 Glerum Jun 2012 A1
20120158146 Glerum Jun 2012 A1
20120158148 Glerum Jun 2012 A1
20120185049 Varela Jul 2012 A1
20120191196 Louis Jul 2012 A1
20120215315 Hochschuler et al. Aug 2012 A1
20120265248 Delecrin Oct 2012 A1
20120265258 Garvey Oct 2012 A1
20120277867 Kana et al. Nov 2012 A1
20120277878 Sommerich et al. Nov 2012 A1
20120296428 Donner Nov 2012 A1
20120303064 Walker Nov 2012 A1
20120330417 Zipnick Dec 2012 A1
20120330419 Moskowitz et al. Dec 2012 A1
20120330424 Zeegers Dec 2012 A1
20120330425 Zipnick Dec 2012 A1
20130013006 Rashbaum Jan 2013 A1
20130018468 Moskowitz et al. Jan 2013 A1
20130018469 Moskowitz et al. Jan 2013 A1
20130023991 Moskowitz et al. Jan 2013 A1
20130041408 Dinville Feb 2013 A1
20130053891 Hawkins Feb 2013 A1
20130053962 Moskowitz et al. Feb 2013 A1
20130110242 Kirwan May 2013 A1
20130150968 Dinville Jun 2013 A1
20130150969 Zipnick Jun 2013 A1
20130166029 Dinville Jun 2013 A1
20130268076 Carlson et al. Oct 2013 A1
20130274883 McLuen et al. Oct 2013 A1
20130310935 Swann Nov 2013 A1
20130338776 Jones Dec 2013 A1
20140074214 Raje et al. Mar 2014 A1
20140074241 McConnell Mar 2014 A1
20140088711 Chin et al. Mar 2014 A1
20140100663 Messerli et al. Apr 2014 A1
20140114420 Robinson Apr 2014 A1
20140121773 Patel et al. May 2014 A1
20140148904 Robinson May 2014 A1
20140148905 Messerli et al. May 2014 A1
20140163682 Lott et al. Jun 2014 A1
20140163683 Seifert et al. Jun 2014 A1
20140172104 Dugal et al. Jun 2014 A1
20140180417 Bergey Jun 2014 A1
20140236297 Iott Aug 2014 A1
20140249629 Moskowitz et al. Sep 2014 A1
20140277509 Robinson et al. Sep 2014 A1
20140277510 Robinson et al. Sep 2014 A1
20140303731 Glerum Oct 2014 A1
20140324171 Glerum Oct 2014 A1
20140371795 Hess et al. Dec 2014 A1
20140379085 Duffield Dec 2014 A1
20150012097 Ibarra Jan 2015 A1
20150018952 Ali Jan 2015 A1
20150025637 Moskowitz et al. Jan 2015 A1
20150045893 Dinville et al. Feb 2015 A1
20150100127 Bal et al. Apr 2015 A1
20150105824 Moskowitz et al. Apr 2015 A1
20150127107 Kim May 2015 A1
20150127109 Brett et al. May 2015 A1
20150134064 Grotz et al. May 2015 A1
20150142116 Aferzon et al. May 2015 A1
20150202051 Tanaka Jul 2015 A1
20150209089 Chataigner et al. Jul 2015 A1
20150250603 Glerum Sep 2015 A9
20150250611 Schifano et al. Sep 2015 A1
20150250612 Schifano et al. Sep 2015 A1
20150265415 Gittings et al. Sep 2015 A1
20150265416 Aferzon et al. Sep 2015 A1
20150272743 Jimenez et al. Oct 2015 A1
20150289988 Ashley et al. Oct 2015 A1
20150305880 Kim Oct 2015 A1
20150305887 McAtamney et al. Oct 2015 A1
20150320568 Ameil et al. Nov 2015 A1
20150335372 Schifano et al. Nov 2015 A1
20150342754 Geebelen et al. Dec 2015 A1
20150374507 Wolters et al. Dec 2015 A1
20160015526 Ali Jan 2016 A1
20160030191 McLuen et al. Feb 2016 A1
20160038299 Chen Feb 2016 A1
20160038845 Mizunaga et al. Feb 2016 A1
20160045326 Hansen et al. Feb 2016 A1
20160045327 Robinson et al. Feb 2016 A1
20160058565 Zappacosta et al. Mar 2016 A1
20160074172 Lee et al. Mar 2016 A1
20160081813 Greenberg et al. Mar 2016 A1
20160100953 Dinville et al. Apr 2016 A1
20160106550 Slivka et al. Apr 2016 A1
20160113777 Gamache Apr 2016 A1
20160120657 Trudeau et al. May 2016 A1
20160151171 Mozeleski et al. Jun 2016 A1
20160166395 Weiman Jun 2016 A9
20160175107 Janowski et al. Jun 2016 A1
20160338845 Ashleigh Nov 2016 A1
20160374831 Duffield Dec 2016 A1
20170056192 Buss Mar 2017 A1
20170100260 Duffield et al. Apr 2017 A1
20170165082 Faulhaber Jun 2017 A1
20170165083 Greenhalgh Jun 2017 A1
20170266016 Faulhaber Sep 2017 A1
20170281358 Wagner et al. Oct 2017 A1
20170296238 Snell et al. Oct 2017 A1
20170303975 Koch et al. Oct 2017 A1
20180104068 Sack Apr 2018 A1
20180110627 Sack Apr 2018 A1
Foreign Referenced Citations (19)
Number Date Country
2013267749 Dec 2013 AU
2730337 Oct 2005 CN
101854887 Oct 2010 CN
102596109 Jul 2012 CN
104822332 Aug 2015 CN
105188580 Dec 2015 CN
105250056 Jan 2016 CN
2389902 Nov 2011 EP
2015077467 Jul 2014 JP
2015501189 Jan 2015 JP
2016524988 Aug 2016 JP
2010092893 Aug 2010 WO
2010092893 Aug 2010 WO
2011035126 Mar 2011 WO
2012047289 Apr 2012 WO
2012117312 Sep 2012 WO
2013062716 May 2013 WO
2016010499 Jan 2016 WO
2016210434 Dec 2016 WO
Non-Patent Literature Citations (16)
Entry
Office Action dated Apr. 9, 2020 in U.S. Appl. No. 16/109,326.
International Search Report and Written Opinion dated Jan. 12, 2018 for International Patent Application No. PCT/US2017/56973.
International Search Report and Written Opinion dated Jan. 23, 2018 for International Patent Application No. PCT/US2017/058109.
International Search Report and Written Opinion dated Dec. 18, 2019 for International Patent Application No. PCT/US2019/47714.
Office Action dated Sep. 3, 2020 in JP Application No. 2019-520880.
Office Action dated Jun. 9, 2020 in U.S. Appl. No. 15/996,189.
Supplementary Partial European Search Report for EP 17 86 5409, dated Jun. 19, 2020 (17 pp).
Supplementary Partial European Search Report for EP 17 86 3072, dated Jun. 25, 2020 (17 pp).
Office Action dated Dec. 30, 2020 in CN Application No. 2017800781366.
Supplementary European Search Report dated Oct. 30, 2020 in EP Application No. EP 17865409.
Office Action dated Nov. 30, 2020 in CN Application No. 2017800805892.
Office Action dated Jun. 17, 2021 in CN Application No. 2017800805892.
Office Action dated Jan. 5, 2021 in JP Application No. 2019543189.
Office Action dated Jun. 24, 2021 in U.S. Appl. No. 16/429,278.
Office Action dated Oct. 21, 2021 in U.S. Appl. No. 16/659,031.
International Search Report and Written Opinion dated Aug. 25, 2016 for International Application No. PCT/US2016/039642.
Related Publications (1)
Number Date Country
20200015986 A1 Jan 2020 US
Continuations (1)
Number Date Country
Parent 15333892 Oct 2016 US
Child 16565003 US